Lorcaserin Extended-Release Tablets and Sinemet CR 100/25
Determining the interaction of Lorcaserin Extended-Release Tablets and Sinemet CR 100/25 and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: lorcaserin
Brand name: Belviq, Belviq XR
Synonyms: Lorcaserin
Generic Name: carbidopa / levodopa
Brand name: Parcopa, Rytary, Sinemet, Sinemet CR, Duopa
Synonyms: Carbidopa and levodopa, Carbidopa and Levodopa
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Lorcaserin Extended-Release Tablets-Sinemet CR 200/50
- Lorcaserin Extended-Release Tablets-Sinequan
- Lorcaserin Extended-Release Tablets-Sinequan (Doxepin Capsules)
- Lorcaserin Extended-Release Tablets-Sinequan (Doxepin Oral Concentrate)
- Lorcaserin Extended-Release Tablets-Sinex Long-Acting
- Lorcaserin Extended-Release Tablets-Sinex Nasal Spray
- Sinemet CR 100/25-Lorcaserin Hydrochloride
- Sinemet CR 100/25-Lorcaserin Tablets
- Sinemet CR 100/25-Lorcet
- Sinemet CR 100/25-Lorcet Plus
- Sinemet CR 100/25-Lorcet Tablets
- Sinemet CR 100/25-Lorlatinib